Sale!

SS-31 10MG

Original price was: £29.99.Current price is: £24.99.

  • Product: SS-31 10MG
  • Synonyms: SS-31, Elamipretide, Bendavia, MTP-131
  • Format: White to off-white lyophilised powder
  • Catalogue specification: ≥99%
  • CAS number: 736992-21-5
  • Molecular formula: C32H49N9O5
  • Molecular weight: 639.8 g/mol
  • Amount: 10mg
  • SKU: 2S10

For laboratory research use only. Not for human or veterinary use.

Availability: In stock

- +

Quality verification status

Janoshik COA available

A third-party analytical certificate is available for this SKU and stated amount.

Verify Janoshik COA

Product Overview

SS-31 10MG is a synthetic aromatic-cationic tetrapeptide research material also known as elamipretide, supplied as white to off-white lyophilised powder in a 10mg catalogue presentation (SKU 2S10). This page describes the stated research identity and batch-oriented catalogue specification; it does not provide an administration protocol.

SS-31 research examines mitochondrial membrane interactions, cardiolipin-associated processes and cellular bioenergetics. Studies span biochemical, cellular, animal and clinical-development settings.

Identity and Specifications

  • Product: SS-31 10MG
  • SKU: 2S10
  • Format: White to off-white lyophilised powder
  • Synonyms: SS-31, Elamipretide, Bendavia, MTP-131
  • Catalogue purity specification: ≥99%
  • CAS number: 736992-21-5
  • Molecular formula: C32H49N9O5
  • Molecular weight: 639.8 g/mol
  • Amount: 10mg

Research Context

The following themes summarise published research on the named molecule or components. They are research contexts, not claims about the supplied ExtolX batch.

Areas of Research

  • cardiolipin and inner-mitochondrial-membrane interactions
  • electron-transport and bioenergetic assays
  • oxidative-stress models
  • mitochondrial structure-function research

Evidence Quality and Limitations

Mechanistic and clinical-development literature exists, but outcomes vary by model and formulation. It does not establish suitability or equivalence of this ExtolX vial.

Storage and Handling

Before reconstitution: Keep the lyophilised vial sealed, dry and protected from light at −20°C or below, subject to the batch-specific supplier documentation. Published SS-31 reference-material data support frozen storage, but the counter-ion and formulation of this ExtolX batch have not been confirmed. Do not transfer conditions from a clinical elamipretide formulation.

After reconstitution: Stability depends on the exact salt or formulation, solvent, concentration, pH and container. Prepare only what the validated method requires. If that method supports frozen storage, use single-use aliquots and avoid repeated freeze–thaw cycles. Use clean laboratory technique, avoid vigorous agitation, and record the preparation and storage history. No numerical solution shelf life has been verified for this ExtolX batch.

Compatibility Limitations

Do not infer solubility or stability from another peptide, blend, amount or pharmaceutical formulation. Use small-scale method development and appropriate analytical controls before committing valuable material.

Laboratory Safety

Handle only in an appropriately equipped laboratory by trained personnel. Use a task-specific risk assessment, suitable personal protective equipment and applicable safety documentation. Avoid ingestion, inhalation, skin contact and environmental release, and dispose of waste in accordance with local requirements.

Sources

Scientific sources last reviewed: 23 August 2026.

Research Use Agreement & Disclaimer

For laboratory research use only. Not for human or veterinary use. Purchasers are responsible for lawful handling, storage and disposal in accordance with applicable regulations and good laboratory practice. Product information is educational and is not medical advice or evidence of efficacy.

Reviews

There are no reviews yet

Only logged in customers who have purchased this product may leave a review.